We are live on ! Find out more
CRVO icon

CervoMed

45 hedge funds and large institutions have $13.7M invested in CervoMed in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 18 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.27% less ownership

Funds ownership: 26.24%24.97% (-1.3%)

6% less funds holding

Funds holding: 4845 (-3)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

35% less capital invested

Capital invested by funds: $20.9M → $13.7M (-$7.24M)

61% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 18

Holders
45
Holders Change
-3
Holders Change %
-6.25%
% of All Funds
0.59%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
7
Reduced
18
Closed
14
Calls
Puts
Net Calls
Net Calls Change

CRVO Hedge Fund Activity: Q2 2025 in Review

45 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2025, worth a combined $13.7M — down 35% from $20.9M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CRVO and 11 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 7 added.

The largest buyer was Morgan Stanley, adding an estimated $2.03M. The largest seller was BlackRock, cutting an estimated $2.08M.

  • 45 institutional investors held CervoMed (CRVO) as of Q2 2025, down from 48 in Q1 2025.
  • Funds reported $13.7M of CervoMed stock for Q2 2025, down 35% quarter-over-quarter.
  • 11 funds opened new CervoMed positions in Q2 2025 and 14 closed out, a net change of -3 holders.
  • The largest CervoMed buyer in Q2 2025 was Morgan Stanley, an estimated $2.03M added.
  • The largest CervoMed seller in Q2 2025 was BlackRock, an estimated $2.08M sold.

Based on aggregated 13F filings for Q2 2025.